This message was sent to ##Email##
This year's conference in the Windy City brought together a record number of attendees, with more than 1,400 clinicians and researchers from across the United States and around the world coming together to share, network, collaborate, and learn about cutting-edge thinking in research and clinical practice.
We would also like to extend a special thank you to all of our speakers, keynotes, poster presenters, and our sponsors and exhibitors for supporting the #ADAA2019 experience. And congratulations again to all of our #ADAA2019 CDLP, Donald F. Klein, and Member Recognition awardees. We invite you to visit our #ADAA2019 Conference snapshot website page. View #ADAA2019 media updates.
We invite all #2019 attendees to complete our brief survey and enter a raffle to win one of four great prizes (including free registration for #ADAA2020!). Your feedback helps ensure that future conferences meet and exceeds attendee expectations. Thank you.
Browse our #ADAA2019 Photo album on Facebook (you don’t need to be active on Facebook to view and download photos).
Thank You to our #ADAA2019 Dine-Around Hosts!
#ADAA2019 brought back Dine-Arounds, a great networking opportunity to dine with active ADAA members, presenters and like-minded professionals. We would like to thank ADAA Board Member Ken Goodman, LCSW for helping organize the Dine-Arounds, as well as our nine hosts for ensuring that a great time was had by all.
Thank you to ADAA's #ADAA2019 Sponsors
Rogers Behavioral Health
American Foundation for Suicide Prevention
Houston OCD Program
Janssen Research and Development LLC
Barn Life Recovery
Beck Institute for Cognitive Behavioral Therapy
Thank You to ADAA's #ADAA2019 Exhibitors
For details on #ADAA2020 sponsorship or exhibiting opportunities, please contact Gabby Oved at firstname.lastname@example.org or 240-485-1031.
Save the Date! #ADAA2020
March 19-22, 2010
San Antonio Marriott Rivercenter
Join us as we celebrate ADAA’s 40th anniversary!
Submission portals and registration opening soon.
ADAA Board News
ADAA is pleased to announce that ADAA members (from left to right) Ken Goodman, LCSW (Private Practice), Sanjay Mathew, MD (Baylor College of Medicine) and Tanja Jovanovic, PhD (Emory University School of Medicine) have been elected to the Board of Directors. Welcome!
ADAA congratulates board member Dr. Charles Nemeroff, MD, PhD on his appointment as ADAA’s first Chief Medical Officer.
ADAA would like to acknowledge and thank departing board members Cindy Aaronson, MSW, PhD and Michael Van Ameringen, MD for their many contributions and dedication to the organization.
ADAA offers a variety of webinars for mental health professionals. Most ADAA professional webinars offer CE/CME and AWSB credits.
Wednesday, April 10, 2019 — Dean McKay, PhD, ABPP presents:
An Old Approach with a New Twist: Applications of Inhibitory Learning in Exposure Therapy
Eligible for 1 CE/CME hour
Wednesday, May 8, 2019 – Debra Kissen, PhD, MHSA, Lynne Siqueland, PhD and Ruth Lippin, LCSW, JD present:
Collaborating with Pediatricians: Tools & Techniques to Enhance Relationships & Care Coordination with Pediatricians in your Community
Eligible for 1 CE/CME Hour
Thursday, June 13, 2019 — David Rosmarin, PhD, ABPP presents:
Spirituality & Mental Health: What Clinicians Need to Know
Eligible for 1 CE/CME hour
Based on member survey requests for more interactive educational initiatives, the Public Education Committee is pleased to announce our first online interactive Fall Forum which will address understanding and treating maternal anxiety and depression. The three-hour conversation will include discussions on the following topics:
Stay tuned for date/time and more details..
- Medications for maternal mental health issues
- Medication complexities during pregnancy and nursing
- Challenges associated with mood/anxiety across pregnancy and motherhood
- Maternal MH screening in pregnancy, post-partum, and infant visits
- Psychotherapy interventions for maternal MH issues
Recent ADAA Recordings
Click here for a full listing of all on-demand webinars.
ADAA is proud to showcase the cutting-edge research conducted by our members. If you are interested in featuring your research lab, please download the flyer here or contact Astrid Masfar: email@example.com
New ADAA Member Blog Post
Avoid the Snake Oil: Pseudoscience and OCD Treatment
by Katie D. Kriegshauser, PhD
Have you been quoted in a recent news article/story? Please let us know so we can share your news with your ADAA colleagues and with our public community (here, through the website and via our social media platforms).
April 2019 A Three-Hour Fix for Phobia, a Four-Day Therapy for OCD, ScientificAmerican.com, Thomas H. Ollendick, PhD
04/08/2019 The Challenge of Going Off Psychiatric Drugs, NewYorker.com, Wayne Goodman, MD
04/05/2019 How to tell when Procrastinating is Actually Anxiety, QZ.com, Andrew Rosen PhD, ABPP, FAACP
04/04/2019 Ketamine a Panacea for Resistant Depression? Not So Fast, Experts Say, Adriana Feder, MD, Beth Salcedo, MD, Alan Schatzberg, MD and Carlos A Zarate, MD
04/04/2019 I Tried the 'If it Only Takes a Minute, Do It Now' Cleaning Hack. Here's What Happened., NBCNews.com Kevin Chapman, PhD
04/03/2019 Songwriting May Hit the Right Therapeutic Note in PTSD, Medscape.com, Beth Salcedo, MD
04/01/2019 Combination Therapy for PTSD Provides No Added Benefit, Medscape.com, Sheila Rauch, PhD
04/01/2019 Immunosuppressant May Extend Ketamine's Antidepressant Effects, Medscape.com, Chadi Abdallah, MD, Rebecca Price, PhD and Samuel Wilkinson, MD
04/01/2019 Ketamine Improves Suicidal Ideation in Veterans with PTSD, MDD, Healio.com, Cristina Sophia Albott, MD
04/01/2019 Patients With Anxiety, Mood Disorders Lack Self-Compassion, Healio.com, Ricks Warren, PhD, ABPP
04/01/2019 Don’t Let Social Anxiety Disorder Hurt Your Business, CraftIndustryAlliance.org, Jennifer Shannon, LMFT
April 2019, Keep Calm and Recycle On, The Oprah Magazine, Karen Cassiday, PhD and Lata K. McGinn, PhD
March 2019, We Need to Start Treating Anxiety and Depression as Chronic Conditions, PsychotherapyNetworker.com, Margaret Wehrenberg, PsyD
03/30/2019 Mental Health Awareness, The360Mag.com, Lata McGinn, PhD
03/29/2019 FDA Approves Spravato, a Fast-Acting Antidepressant Nasal Spray, TMC.edu, Sanjay Mathew, MD
03/28/2019 The Remote Control Brain, NPR.org, Darin Dougherty, MD
03/25/2019 Coping with College Rejection, JournalGazette.net, Mary Alvord, PhD
Member Publications and Research News
Have you published a new book for consumers or professionals? Please let us know so we can highlight your new publication here and on the ADAA website.
ADAA is also interested in highlighting our members' research. Please send us your recent research news for us to post and share.
April 2019 Issue — Volume 36, Issue 4
FOCUS ON: DEPRESSION DIVERSITY IN TIME AND PLACE
Early View Article:
Symptom profiles of late‐life anxiety and depression: The influence of migration, religion and loneliness
Emma Curran, Michael Rosato, Janine Cooper, Christine A. Mc Garrigle, Gerard Leavey
Version of Record online: 03 April 2019
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online at no charge to ADAA members. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans. Per the ISI Journal Citation Reports Rankings for 2017, the Depression and Anxiety impact factor is 5.043. The journal ranks 19 of 142 in psychiatry journals; 8 of 77 in psychology journals; 5 of 121 for psychology clinical journals, and 15 of 139 for psychiatry social science journals. Google Scholar psychiatry journal ranking (spring 2017) ranked Depression and Anxiety #19 of 20.
Murray B. Stein, MD, MPH - Editor-in-Chief
Meet the Journal Editorial Board
| || RESEARCH AND PRACTICE NEWS|
Recently the Food and Drug Administration approved esketamine (Spravato) for treatment-resistant depression to be administered under physician supervision. It’s a derivative of ketamine, a drug commonly used for anesthesia that has also been used recreationally. This is the second time in the past year that a new drug related to a street drug has entered the market, following last June’s FDA approval of Epidiolex, a form of medical marijuana for treating childhood seizures. This openness to new treatments is a signal to the medical community that best practices can and must change. It’s also a signal that practitioners must be trained to supervise “the trip.”
USA Today via Florida Today
Sadly, it’s estimated that one-fifth of adolescents suffer from a serious mental health disorder at some point. As a result, nearly 7,000 young people between the ages of 10 and 24 died from suicide in 2017. This begs the question: why is this happening to our children so frequently?
Psychotherapy is not what most people think of as a quick fix. From its early Freudian roots, it has taken the form of 50- to 60-minute sessions repeated weekly (or more often) over a period of months or even years. For modern cognitive-behavioral therapy, 10 to 20 weekly sessions is typical. But must it be so?
Self-compassion partially mediated the relationship between maladaptive perfectionism and psychiatric symptoms in patients with bipolar disorder, according to study data published in the Journal of Affective Disorders.
In patients with remitting depression, higher suicidal ideation during the current depressive episode, residual symptoms at remission, and greater severity of side effects at remission may be predictors of subsequent relapse, according to a study published in the Journal of Affective Disorders.
In March, three people connected to mass school shootings died by suicide, raising questions about the lingering effects of such trauma on a person’s mental health.
Two teenagers who survived the 2018 shooting at Marjory Stoneman Douglas High School in Parkland, FL, took their own lives within days of each other. The father of a child killed in the 2012 Sandy Hook Elementary School shooting in Newtown, CT, died by suicide a few days later.
Suicide can occur in clusters, especially among teens. But it’s too early to tell if these deaths are connected in any way, are related to having experienced similar mass traumas — or if they simply occurred close together by chance, says April Foreman.
Our thoughts and fears, movements and sensations all arise from the electrical blips of billions of neurons in our brain. Streams of electricity flow through neural circuits to govern these actions of the brain and body, and some scientists think that many neurological and psychiatric disorders may result from dysfunctional circuits.
As this understanding has grown, some scientists have asked whether we could locate these faulty circuits, reach deep into the brain and nudge the flow to a more functional state, treating the underlying neurobiological cause of ailments like tremors or depression.
Harvard Health Publishing
Discontinuation and change are part of life. We all start and stop various activities. Jobs change, relationships change. So, too, may medical treatments, such as antidepressants that help many people navigate depression and anxiety. Planning changes in advance tends to make things easier and smoother. You may start a medication for treatment and discover that it’s not helping your particular medical issue. Or perhaps you’re having side effects. Or maybe your condition has improved, and you no longer need the drug. If so, working with your doctor to change or stop taking an antidepressant slowly may help you avoid uncomfortable symptoms known as discontinuation syndrome.
Perinatal depression — depression that occurs during pregnancy or after the birth of a child — is surprisingly common, affecting about one in seven women. And, although depression is debilitating at any time, it may carry a particularly heavy public health burden during the transition to parenthood. Women with depression are less likely to obtain medical care for themselves and their babies, and may struggle to bond with their infants. It’s no wonder that the children of depressed mothers experience heightened long-term risk of emotional and behavioral problems.
Despite this grim picture, a new report from the U.S. Preventive Services Task Force offers some hope.
A popular smartphone app based on cognitive behavioral therapy and mindfulness showed efficacy in individuals with symptoms of anxiety and depression, data presented at the Anxiety and Depression Association of America annual meeting showed.
There has been increased demand for technology-based behavioral health tools to ease the burden of mental illness, according to the meeting abstract.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063